Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrecizumab in acute heart failure
NCT04252937Phase 2Unknown
- Sponsor
- GREAT Network Italy
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- IgG Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of adrecizumab in Acute Heart Failure (AHF), sponsored by GREAT Network Italy. Status: unknown.
02
Drugs
adrecizumab
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT04252937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04252937.